Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Lenalidomide is an immunomodulatory oral thalidomide derivate with activity in a variety of hematologic malignancies. Ferrajoli and colleagues explored lenalidomide at a starting dose of 10mg daily without interruption for relapsed and refractory CLL.

Lenalidomide Has Activity in CLL